Asthma - Drug Pipeline Landscape, 2022 | Allergy Therapeutics Plc, Alveolus Bio Inc, Alvotech SA, Amgen Inc

Global Insight Services have recently published a report on Asthma - Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

Asthma is a chronic inflammatory disease of the lungs. The airways in the lungs become narrow due to inflammation and tightening of the muscles around the small airways and also due to excess mucus. It is characterised by airflow obstruction and triggers bronchospasms.

Signs and symptoms of asthma includes shortness of breath, chest tightness, recurrent episodes of wheezing and cough. These symptoms vary from person to person. The symptoms get worse during night or with exercise.

View Detailed Report Description : https://www.globalinsightservices.com/reports/asthma-drug-pipeline-landscape-2022/

Asthma is caused by a combination of environmental and genetic interactions. Allergies can raise the development of asthma, certain respiratory infections such as RSV can affect children. Exposure to tobacco smoke and other sources of air pollution can increase the risk.

There is currently no precise test for the diagnosis, which is typically based on the pattern of symptoms and response to therapy over time. The condition is suspected with a history of recurrent wheezing, coughing or difficulty breathing. The main tests include spirometry, peak flow test and FeNO test.

Asthma treatment aims in reducing the inflammation and bronchoconstriction of the airways. This involves the anti-inflammatory agents for the mildest symptoms. Other medications involve, bronchodilators, anticholinergics, corticosteroids and biologics. Avoidance of triggers is a key component of improving control and preventing attacks.

Report Highlights

Global Insight Service's, Asthma - Drug Pipeline Landscape, 2022 report provides an overview of the Asthma pipeline drugs. This report covers detailed insights on Asthma drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Asthma pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS31009

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Purchase your copy now : https://www.globalinsightservices.com/checkout/single_user/GIS31009

Report Segmentation

Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Key Players

• 3SBio Inc
• 4D Pharma Plc
• AazeinTx Inc
• AB Science SA
• Adial Pharmaceuticals Inc
• Advagene Biopharma Co Ltd
• Aeon Respire Inc
• Akari Therapeutics Plc
• Aldeyra Therapeutics Inc
• Algomedix Inc
• ALK-Abello AS
• Allakos Inc
• Allergy Therapeutics Plc
• Alveolus Bio Inc
• Alvotech SA
• Amgen Inc

Request For Customization : https://www.globalinsightservices.com/request-customization/GIS31009

Reasons to buy Asthma Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.